Ibandronic acid - CAS 114084-78-5
Catalog number: 114084-78-5
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
Ibandronic acid is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
Canonical SMILES:
1. Oral versus intravenous ibandronic acid: a comparison of treatment options for metastatic bone disease
Kyriaki Mystakidou, Evangelia Stathopoulou. J Cancer Res Clin Oncol (2008) 134:1303–1310
Bisphosphonates are the standard of care for treating MBD (Coleman 2001; Diel et al. 2000; Mystakidou et al. 2005), and several are used in the clinical setting (zoledronic acid, ibandronic acid, pamidronate and clodronate). Ibandronic acid is the only bisphosphonate available in both oral and intravenous (IV) formulations. Results from individual phase 3 trials suggest similar efficacy of oral and IV ibandronic acid for the prevention of SREs in women with breast cancer and MBD (Diel et al. 2000; Body et al. 2003, 2004). However, the efficacy and safety of oral and IV formulations of ibandronic acid have not been evaluated previously in a head-to-head study. The primary objective of this study was to evaluate the efficacy (clinical response) and safety of oral and IV ibandronic acid in patients with various tumour types. The secondary study objective was to determine the influence of ibandronic acid on analgesic use, metastatic bone pain, and QoL.
2. Modulating Effect of Matrices with Calcium Phosphate Coating on Cytotoxicity of Strontium Ranelate and Ibandronic Acid In Vitro
I. A. Khlusov, N. V. Ryazantseva, A. I. Vengerovskii, K. A. Nechaev. Bulletin of Experimental Biology and Medicine, Vol. 157, No. 2, June, 2014 PHARMACOLOGY AND TOXICOLOGY
Ibandronic acid (IA) increased intracellular concentration of ROS by 57% (Table 1), then cell death occurred. Metabolic mechanism of nitrogen-containing Ibandronic acid (IA) and other bisphosphonates is associated with the inhibition of farnesyl diphosphate synthase, the enzyme of mevalonate pathway of cholesterol, sterols and isoprenoid lipids synthesis. Geranyl pyrophosphate and farnesyl pyrophosphate activating regulatory proteins Ras, Rho, Rac, Rab, and Cdc42 with guanosine triphosphatase function are synthesixed via the mevalonate pathway. Rac proteins control activity of NADPH oxidase catalyzing the production of superoxide anion radical.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 51-52-5 Propylthiouracil

(CAS: 51-52-5)

Propylthiouracil is a thyroperoxidase and 5'-deiodinase inhibitor. It is a thiouracil-derived drug used to treat hyperthyroidism (including Graves' disease) by ...

S Tag Peptide

S Tag Peptide, a 15 amino acid peptide derived from RNase A, is an oligopeptide used for improving protein solubility.

CAS 2117404-84-7 BAY 677

BAY 677
(CAS: 2117404-84-7)

BAY 677 is an inactive control for BAY 678 and a human neutrophil elastase (HNE) inhibitor.

(CAS: 202914-21-4)


(CAS: 178946-89-9)

C-DIM12 is a novel synthetic activator of Nurr1. C-DIM12 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro. .

CAS 126643-37-6 KT 5823

KT 5823
(CAS: 126643-37-6)

KT 5823 is a cell-permeable, selective inhibitor of cGMP-dependent protein kinase (PKG) (Ki values are 0.23, 4 and > 10 μM for inhibition of PKG, PKC and PKA re...

CAS 2998-57-4 Estramustine

(CAS: 2998-57-4)

Estramustine, a derivative of estradiol, is an alkylating antineoplastic agent that is used in the treatment of prostate cancer throughout the world.

CAS 1626359-59-8 sulfo-SPDB-DM4

(CAS: 1626359-59-8)

sulfo-SPDB-DM4 is adrug-linker conjugate for ADC and DM4 with a reactive linker sulfo-SPDB, which can react with antibody to make antibody drug conjugate.

Chemical Structure

CAS 114084-78-5 Ibandronic acid

Quick Inquiry

Verification code

Featured Items